Flecainide

Flecainide structure

Flecainide is a prominent oral antiarrhythmic agent that has been a cornerstone in medical therapeutics for many years. While it remains a preferred choice for specific cardiac arrhythmias, understanding its mechanism, FDA approvals, dosages, and side effects is pivotal for appropriate clinical use.

Introduction

Flecainide is a well-established medication primarily utilized for its antiarrhythmic properties. Since its introduction, it has been widely prescribed for various cardiac conditions. A notable aspect of its profile is the minimal impact on liver enzymes, although rare instances of acute liver injury have been reported.

File:Flecainide 3D ball.png

Flecainide 3D ball

Mechanism of Action

Flecainide, a benzamide derivative, shares its ancestral roots with the local anesthetic procaine. Functionally, its electrophysiological properties mirror that of quinidine, categorizing it under the antiarrhythmic Class IC.

The drug predominantly functions by inhibiting open sodium channels and modulating outward potassium channels. This dual-channel action leads to:

• Diminished cardiac automaticity.
• Prolonged refractory periods.
• Decelerated conduction in cardiac tissues.

FDA Approval

Gaining its official FDA approval in 1985, Flecainide has established itself in the medical regimen for specific cardiac conditions. Its primary indications encompass:

• Prophylaxis and suppression of severe ventricular arrhythmias.
• Conversion of supraventricular tachyarrhythmias.
• Maintenance of normal sinus rhythm in patients devoid of structural heart anomalies, particularly when alternative agents failed to provide therapeutic results.

Dosage and Administration

Flecainide is available for administration in tablet forms, with varying strengths of 50 mg, 100 mg, and 150 mg. Both generic and the branded version, Tambocor, are accessible to patients. For adults, the standard maintenance dosage ranges between 50 mg to 200 mg, administered twice daily.

Side Effects and Adverse Reactions

Like all therapeutics, Flecainide has its array of side effects. While most are mild and transient, it's essential for clinicians and patients to be aware of them. The commonly reported side effects encompass:

• Dizziness: Affecting the equilibrium.
• Visual disturbances: Including blurring.
• Headache: Varying intensities and durations.
• Fatigue: Marked by a generalized sense of tiredness.
• Anxiety: Psychological distress.
• Gastrointestinal disturbances: Often presenting as stomach upset.
• Nausea: With or without the presence of vomiting.

In summary, while Flecainide stands as a potent antiarrhythmic agent, its efficacy is complemented by a strong safety profile. Its minimal hepatic side effects make it a preferred choice, but like all medications, understanding its complete profile is vital for optimal clinical outcomes. List of antiarrhythmic agents:

• Amiodarone
• Disopyramide
• Dofetilide
• Dronedarone
• Flecainide
• Ivabradine
• Mexiletine
• Procainamide
• Propafenone
• Quinidine

• Dailymed label info on Flecainide
• FDA Flecainide